Ochre Bio announces partnership with Boehringer Ingelheim to develop novel regenerative treatments for patients with advanced liver disease Read more
European Commission Approves Pfizer’s EMBLAVEO for Patients with Multidrug-Resistant Infections and Limited Treatment Options Read more
ImmunityBio Announces FDA Approval of ANKTIVA, First-in-Class IL-15 Receptor Agonist for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Read more
TriLink BioTechnologies Announces New San Diego Facility for Late Phase mRNA Drug Substance Production Read more
Evotec and Variant Bio enter strategic partnership to discover and develop fibrosis treatments Read more
Outrun Therapeutics launches with a $10m seed financing from M Ventures and MP Healthcare Venture Management to develop a protein stabilisation pipeline Read more
Essential Pharma Announces the Acquisition of Reminyl (galantamine hydrobromide) Oral Capsules Read more
Clearmind Medicine Announces Exclusive Licensing Agreement for Generation 3.0 Psychedelic Compounds for the Treatment of Mental Disorders Read more